SIMON PEDDER, PH.D.

Corporate Board Profile

Tech Score: 0/100

Oncotelic Therapeutics, Inc.

Filing Date	Source Excerpt
2016-04-25	Dr. Pedder currently serves as the Vice President of Corporate Strategy and Business Development of Athenix, Inc., a private global specialty oncology pharmaceutical company. The Board believes Dr. Pedder's experience in cancer drug development and his experience managing public life sciences companies qualify Dr. Pedder to serve as a director of the Company and led to the Board's conclusion that Dr. Pedder should be a member of the Board of Directors.

Filing Date

Source Excerpt

2016-04-25

Dr. Pedder currently serves as the Vice President of Corporate Strategy and Business Development of Athenix, Inc., a private global specialty oncology pharmaceutical company. The Board believes Dr. Pedder's experience in cancer drug development and his experience managing public life sciences companies qualify Dr. Pedder to serve as a director of the Company and led to the Board's conclusion that Dr. Pedder should be a member of the Board of Directors.

Data sourced from SEC filings. Last updated: 2026-02-03